Deep Track Capital’s RAPT Therapeutics RAPT Stock Holding History

Deep Track Capital’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-110,448	Closed	-$3.74M	–	68
2025 Q4	$3.74M	Sell	110,448 -640,974	-85%	-$19.9M	0.07%	52
2025 Q3	$19.4M	Hold	751,422	–	–	0.54%	36
2025 Q2	$6.01M	Sell	751,422 -1	-0%	-$8	0.19%	51
2025 Q1	$7.33M	Hold	751,423	–	–	0.24%	51
2024 Q4	$9.5M	Buy	+751,423	New	+$9.54M	0.35%	49
2024 Q1	–	Sell	-224,246	Closed	-$44.6M	–	77
2023 Q4	$44.6M	Buy	224,246 +36,746	+20%	+$4.55M	1.49%	28
2023 Q3	$24.9M	Buy	187,500 +61,930	+49%	+$10.1M	0.96%	30
2023 Q2	$18.8M	Buy	125,570 +54,166	+76%	+$8.44M	0.87%	33
2023 Q1	$10.5M	Sell	71,404 -91,714	-56%	-$18.5M	0.43%	46
2022 Q4	$25.8M	Buy	+163,118	New	+$26.1M	1.08%	33

Deep Track Capital's RAPT Position: Q1 2026 in Review

Deep Track Capital sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 110,448 shares — an estimated $3.74M sold.

Deep Track Capital first reported a position in RAPT in Q4 2022 and held it in 10 quarters. The position peaked at $44.6M in Q4 2023. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

Deep Track Capital reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
Deep Track Capital sold 110,448 RAPT Therapeutics shares in Q1 2026, an estimated $3.74M.
Deep Track Capital first reported a position in RAPT Therapeutics in Q4 2022 and held it in 10 quarters.
Deep Track Capital's RAPT Therapeutics position peaked at $44.6M in Q4 2023.
0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on Deep Track Capital's 13F filing for Q1 2026, filed 15 May 2026.